Literature DB >> 15235897

Live donor liver transplantation: staging hepatectomy in a Jehovah's Witness recipient.

Nicolas Jabbour1, Singh Gagandeep, Rodrigo Mateo, Linda Sher, Randy Henderson, Rick Selby, Yuri Genyk.   

Abstract

Orthotopic liver transplantation (OLT) is usually associated with significant blood loss and frequently requires the usage of blood products. OLT has been offered sparingly in Jehovah's Witness (JW) patients because of their refusal to accept blood products for religious reasons. Several innovations have made surgery safer in these patients. These include the pre-operative use of erythropoietin to increase red cell mass, the use of intraoperative cell salvage and acute normovolemic hemodilution, and judicious postoperative blood testing. Thoughtful perioperative decision-making and careful surgical techniques remain the cornerstone to a successful outcome. We report our experience in a two-stage hepatectomy done for a JW patient who underwent live donor liver transplant from his mother, also a JW, without blood transfusion. The recipient had an unusually enlarged left lateral segment of the liver which was densely adherent to the spleen. Removing these adhesions in the presence of significant portal hypertension would have resulted in considerable blood loss. This was successfully avoided by leaving this portion of the liver attached to the spleen while proceeding with the hepatectomy. The right lobe of the liver from the donor was then implanted uneventfully. Two weeks later the remaining segment of the recipient liver was removed without incident. The two-stage procedure was life-saving in this JW patient. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15235897     DOI: 10.1007/s00534-003-0877-0

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  6 in total

Review 1.  Transfusion contracts for Jehovah's Witnesses receiving organ transplants: ethical necessity or coercive pact?

Authors:  K A Bramstedt
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

2.  Ruptured intrahepatic biliary intraductal papillary mucinous neoplasm in a Jehovah's Witness patient.

Authors:  Sangchul Yun; Dongho Choi
Journal:  Int Surg       Date:  2014 Sep-Oct

Review 3.  Primary sclerosing cholangitis as an intractable disease.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2012-02

4.  Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.

Authors:  Randeep Kashyap; Parvez Mantry; Rajeev Sharma; Manoj K Maloo; Saman Safadjou; Yanjie Qi; Ashok Jain; Benedict Maliakkal; Charlotte Ryan; Mark Orloff
Journal:  J Gastrointest Surg       Date:  2009-05-09       Impact factor: 3.452

Review 5.  Recurrence of cholestatic liver disease after living donor liver transplantation.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Junichi Kaneko; Junichi Togashi; Yuichi Matsui; Noriyo Yamashiki; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 6.  Review of abdominal solid organ transplantation in Jehovah's Witness patients.

Authors:  Rodrigo S Figueiredo; Rohan G Thakkar; Paul R Ainley; Colin H Wilson
Journal:  World J Transplant       Date:  2019-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.